CD276 and prostate carcinoma: B7‐H3 is expressed at a low level in normal tissues and blood vessels [14], but its expression is abnormally up‐regulated in prostate cancer, oral cancer, colorectal cancer and osteosarcoma and is positively correlated with poor prognosis [15, 16, 17, 18].